Back to KRYS

Frazier Life Sciences Management, L.P. → KRYS

Frazier Life Sciences Management, L.P. KRYS Position History

Krystal Biotech, Inc. • Healthcare

Quarters held
4
Latest value
$130.1M
Q3 2026
Peak value
$178.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$120.4M
Q1 2026$124.3M
Q2 2026$178.9M
Q3 2026$130.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$130.1M391.3K——
Q2 2026$178.9M481.3K——
Q1 2026$124.3M481.3K——
Q4 2025$120.4M488.5K——

Other funds holding KRYS

Other Frazier Life Sciences Management, L.P. positions

MIRM

MIRUM PHARMACEUTICALS INC

$899.1M
MIRM

MIRUM PHARMACEUTICALS INC

$709.4M
MIRM

MIRUM PHARMACEUTICALS INC

$656.5M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$613M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$594.4M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$542.4M
MIRM

MIRUM PHARMACEUTICALS INC

$536.7M
NAMSW

NEWAMSTERDAM PHARMA COMPANY

$461.8M